Delivery Order SPE2DB20D7061-SPE2DB25FSMV6
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD7RC, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,881.62 firm-fixed-price delivery order is for the supply of Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract valued at $1,210.55 to AmerisourceBergen Drug Corp for the supply of 4,566,110,813 units of the prescription drug Vyvanse 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB63L, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,620.22 firm fixed-price delivery order is for the supply of 4,567,939,735 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. This delivery order is part of a larger Indefinite...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEJP1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,579.86 firm fixed-price delivery order is for the supply of 4,567,968,732 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. This award is not a set-aside contract....
This federal contract award is a delivery order (SPE2DB22D3301|SPE2DB25FX9EQ) from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 40 mg Vyvanse capsules. The $1,613.10 firm fixed-price contract has a completion date of January 30, 2025 and was awarded on January 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB7Q8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,567,942,388 units of the prescription medication Vyvanse 40 mg capsules, with a ceiling value of $3,798.80. This award is not set-aside and is a firm fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any subcontractors. The...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FF2V4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,069.14 firm fixed-price delivery order is for the supply of 4563430867 Vyvanse 40 mg capsules. The contract has an ultimate completion date of January 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, registered in the System for Award Management (SAM.gov) since...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,196,506 units of Vyvanse 40 mg capsules. The $2,240.98 contract has an ultimate completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves...
This federal contract award with ID SPE2DX15D3108|SPE2DX24F27TW was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major healthcare supply provider for the U.S. Department of Defense. The $3,958.34 firm fixed price delivery order is for the supply of 4,565,805,293 units of the prescription drug Vyvanse 60 mg capsules. The contract has a completion date of September 16, 2024 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a large pharmaceutical...
This federal contract award, with ID SPE2DB25D3012|SPE2DB25FWWUC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,783.60 firm fixed-price delivery order is for the supply of 4,567,966 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 11, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...